ECSP066564A - Formulaciones de tableta de liberación extendida de venlafaxina - Google Patents

Formulaciones de tableta de liberación extendida de venlafaxina

Info

Publication number
ECSP066564A
ECSP066564A EC2006006564A ECSP066564A ECSP066564A EC SP066564 A ECSP066564 A EC SP066564A EC 2006006564 A EC2006006564 A EC 2006006564A EC SP066564 A ECSP066564 A EC SP066564A EC SP066564 A ECSP066564 A EC SP066564A
Authority
EC
Ecuador
Prior art keywords
extended release
venlafaxina
formulations
release tablet
relates
Prior art date
Application number
EC2006006564A
Other languages
English (en)
Inventor
Michael Rowley
Angela Potts
Eduard Sims
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP066564A publication Critical patent/ECSP066564A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Está invención se relaciona con una formulación de dosificación en tabletas de liberación extendida del antidepresivo clorhidrato de venlafaxina o de una forma óptica del mismo que tiene biodisponibilidad mejorada.
EC2006006564A 2003-10-13 2006-05-12 Formulaciones de tableta de liberación extendida de venlafaxina ECSP066564A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03256439A EP1523981A1 (en) 2003-10-13 2003-10-13 Extended release formulations of venlafaxine

Publications (1)

Publication Number Publication Date
ECSP066564A true ECSP066564A (es) 2006-10-17

Family

ID=34354597

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006564A ECSP066564A (es) 2003-10-13 2006-05-12 Formulaciones de tableta de liberación extendida de venlafaxina

Country Status (15)

Country Link
US (1) US20050136109A1 (es)
EP (2) EP1523981A1 (es)
KR (1) KR20060118481A (es)
CN (1) CN1889939A (es)
AT (1) ATE409031T1 (es)
AU (1) AU2004283439A1 (es)
CA (1) CA2546203A1 (es)
CO (1) CO5690567A2 (es)
DE (1) DE602004016761D1 (es)
DK (1) DK1677776T3 (es)
EC (1) ECSP066564A (es)
ES (1) ES2313059T3 (es)
NO (1) NO20062143L (es)
WO (1) WO2005039555A1 (es)
ZA (1) ZA200603822B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1476139B1 (en) * 2002-02-21 2017-05-17 Valeant Pharmaceuticals Luxembourg S.à.r.l. Controlled release dosage forms
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
CA2507685A1 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
EP1473030B2 (en) † 2003-05-02 2014-05-14 Dexcel Ltd. Extended release Venlafaxine tablet formulation
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN106176678A (zh) 2008-04-18 2016-12-07 因泰克制药有限公司 卡比多巴/左旋多巴胃滞留给药
EP2378883B1 (en) * 2008-12-04 2015-12-23 Intec Pharma Ltd. Zaleplon gastroretentive drug delivery system
EP2726066B1 (en) 2011-06-28 2021-03-31 Neos Therapeutics, LP Dosage forms of amphetamine for oral administration
CN109771380A (zh) * 2017-11-10 2019-05-21 连云港恒运药业有限公司 去甲文拉法辛盐酸盐药物组合物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
DE10208335A1 (de) * 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
AR039162A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Formulaciones de venlafaxina de liberacion extendida
AU2003226751A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
BR0311693A (pt) * 2002-06-10 2005-03-22 Wyeth Corp Sal de formato de o-desmetil-venlafaxina

Also Published As

Publication number Publication date
AU2004283439A1 (en) 2005-05-06
CN1889939A (zh) 2007-01-03
US20050136109A1 (en) 2005-06-23
KR20060118481A (ko) 2006-11-23
CA2546203A1 (en) 2005-05-06
EP1677776B1 (en) 2008-09-24
DE602004016761D1 (de) 2008-11-06
DK1677776T3 (da) 2009-01-19
ATE409031T1 (de) 2008-10-15
ZA200603822B (en) 2008-05-28
WO2005039555A1 (en) 2005-05-06
EP1677776A1 (en) 2006-07-12
EP1523981A1 (en) 2005-04-20
NO20062143L (no) 2006-07-07
CO5690567A2 (es) 2006-10-31
ES2313059T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
NO20033556L (no) Farmasöytiske formuleringer
PT1501534E (pt) Formulacoes farmaceuticas
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
NO20043367L (no) Oralt farmasoytisk preparat
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
GT200700096A (es) Compuestos de pirazolina
SK4326U (sk) Farmaceutická kompozícia s predĺženým uvoľňovaním
DE602005027540D1 (de) Feste formulierungen von ospemifen
MA31430B1 (fr) Formulation a liberation prolongee de nevirapine
SE9901077D0 (sv) Novel use
ECSP066564A (es) Formulaciones de tableta de liberación extendida de venlafaxina
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
ATE352305T1 (de) Stabile pharmazeutische zusammensetzungen mit desloratadine
NO331227B1 (no) Lineaere basiske forbindelser som har NK-2 antagonistaktivitet, farmasoytiske formuleringer derav og anvendelse av samme for fremstilling av farmasoytiske formuleringer
NO20063293L (no) Farmasoytiske forbindelser
ITMI20032175A1 (it) Formulazioni farmaceutiche di bisfosfonati destinate
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
ATE409032T1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung
ITMI20030018A1 (it) Procedimento per la preparazione di composti mono-
DK1919867T3 (da) Lisofyllinanaloger og farmaceutiske anvendelser heraf